Advaccine Biopharmaceuticals Suzhou Co., Ltd. is a biotechnology company developing innovative vaccines in BioBay of Suzhou Industrial Park. The company focuses on the research of genetic engineering vaccine, DNA vaccine, innovative vaccine adjuvant technology. There is a systematic distribution of intellectual property in china and abroad.
The company uses these technologies, mainly engaged in the research and development of antiviral vaccines, especially the company’s innovated vaccine for viral pneumonia possesses the leading technology worldwide.
Clinical trials are being conducted for the COVID-19 DNA vaccine, co-developed by Advaccine and INOVIO Pharmaceuticals simultaneously in China and the United States. The company’s innovative vaccine for respiratory syncytial virus (RSV) is under clinical investigation abroad and its progress of research and development is in the forefront of the world.